Treatment of the myeloid/lymphoid neoplasm with FGFR1 rearrangement with FGFR1 inhibitor. [electronic resource]
Producer: 20191223Description: 1880-1882 p. digitalISSN:- 1569-8041
- Administration, Oral
- Eosinophilia -- drug therapy
- Humans
- Lymphoma -- drug therapy
- Male
- Middle Aged
- Myeloproliferative Disorders -- drug therapy
- Oncogene Proteins, Fusion -- genetics
- Protein Kinase Inhibitors -- pharmacology
- Receptor, Fibroblast Growth Factor, Type 1 -- antagonists & inhibitors
- Treatment Outcome
No physical items for this record
Publication Type: Case Reports; Letter; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.